skip to main content

H.R. 2883 (117th): Stop Stalling Access to Affordable Medications

Call or Write Congress

To enable the Federal Trade Commission to deter filing of sham citizen petitions to cover an attempt to interfere with approval of a competing generic drug or biosimilar, to foster competition and facilitate the efficient review of petitions filed in good faith to raise legitimate public heath concerns, and for other purposes.

The bill’s titles are written by its sponsor.

Sponsor and status

Hakeem Jeffries

Sponsor. Representative for New York's 8th congressional district. Democrat.

Read Text »
Last Updated: Apr 28, 2021
Length: 6 pages
Introduced
Apr 28, 2021
117th Congress (2021–2023)
Status
Died in a previous Congress

This bill was introduced on September 29, 2021, in a previous session of Congress, but it did not receive a vote.

Although this bill was not enacted, its provisions could have become law by being included in another bill. It is common for legislative text to be introduced concurrently in multiple bills (called companion bills), re-introduced in subsequent sessions of Congress in new bills, or added to larger bills (sometimes called omnibus bills).

Cosponsors

8 Cosponsors (5 Democrats, 3 Republicans)

Source

Position statements

What legislators are saying

Rep. Ted Budd Sponsors Bill to Increase Access to Affordable Prescription Drugs
    — Sen. Ted Budd [R-NC] (Co-sponsor) on Aug 12, 2022

More statements at ProPublica Represent...

What stakeholders are saying

R Street Institute SpendingTracker.org estimates H.R. 2883 will save $86 million through 2032.

History

Apr 28, 2021
 
Introduced

Bills and resolutions are referred to committees which debate the bill before possibly sending it on to the whole chamber.

Sep 29, 2021
 
Ordered Reported

A committee has voted to issue a report to the full chamber recommending that the bill be considered further. Only about 1 in 4 bills are reported out of committee.

H.R. 2883 (117th) was a bill in the United States Congress.

A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.

Bills numbers restart every two years. That means there are other bills with the number H.R. 2883. This is the one from the 117th Congress.

This bill was introduced in the 117th Congress, which met from Jan 3, 2021 to Jan 3, 2023. Legislation not passed by the end of a Congress is cleared from the books.

How to cite this information.

We recommend the following MLA-formatted citation when using the information you see here in academic work:

“H.R. 2883 — 117th Congress: Stop Stalling Access to Affordable Medications.” www.GovTrack.us. 2021. April 1, 2023 <https://www.govtrack.us/congress/bills/117/hr2883>

Where is this information from?

GovTrack automatically collects legislative information from a variety of governmental and non-governmental sources. This page is sourced primarily from Congress.gov, the official portal of the United States Congress. Congress.gov is generally updated one day after events occur, and so legislative activity shown here may be one day behind. Data via the congress project.